SEC Form 4 research
| Issuer | ADIAL PHARMACEUTICALS, INC. |
|---|---|
| Tickers | ADIL, AZR |
| Reporting owners | 17 |
| Officers and directors | 6 |
| Last public filing | 2026-10-31 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-30 | 2026-10-28 | Davidson Matt | A | 333,830 | Not reported | Not reported |
| 2026-10-30 | 2026-10-28 | Davidson Matt | A | 31,914 | Not reported | Not reported |
| 2026-10-30 | 2026-10-28 | Davidson Matt | A | 286,044 | Not reported | Not reported |
| 2026-10-30 | 2026-10-28 | Davidson Matt | A | 232,417 | $0 | Not reported |
| 2026-10-30 | 2026-10-28 | Davidson Matt | A | 101.3 | Not reported | Not reported |
| 2026-10-30 | 2026-10-28 | Davidson Matt | A | 232,417 | $0 | Not reported |
| 2026-10-30 | 2026-10-28 | Davidson Matt | A | 1,822.13 | Not reported | Not reported |
| 2026-09-21 | 2026-09-17 | Young Wendy B. | A | 25,666 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.